Introduction
Ginsenosides, the main substances with pharmacological effects in ginseng (Panax ginseng Meyer), are divided into protopanaxadiol (PPD) and protopanaxatriol (PPT) types according to the number and position of the hydroxyl groups. PPD-type ginsenosides include different sugars linked to C-3 and C-20 of the aglycon PPD skeleton, whereas PPT-type ginsenosides contain different sugars linked to C-6 and C-20 of the aglycon PPT (APPT) skeleton. The C-6 outer sugar of the PPT-type ginsenosides is glucose, rhamnose, or xylose, whereas the C-6 inner sugar and the C-20 sugar are always glucose [1] . PPT-type ginsenosides consist of Re, R , and APPT according to the presence or absence of different types of sugars. PPT-type ginsenosides have anti-diabetic, anti-inflammatory, and anti-amnestic activities, and may protect against Alzheimer's disease and the UVB-induced apoptosis of keratinocyte [2] [3] [4] [5] [6] [7] .
Ginsenosides with one sugar or no sugars are more rapidly absorbed into the bloodstream and have better pharmacological effects than ginsenosides with three or four sugars [8, 9] . APPT, a ginsenoside with no linked sugars, has excellent pharmacological effects such as memory enhancement and antitumor activities [10, 11] . APPT can be transformed from PPT-type ginsenosides, including R 1 Aglycon protopanaxatriol (APPT) has valuable pharmacological effects such as memory enhancement and tumor inhibition. β-Glycosidase from the hyperthermophilic bacterium Dictyoglomus turgidum (DT-bgl) hydrolyzes the glucose residues linked to APPT, but not other glycoside residues. β-Glycosidase from the hyperthermophilic bacterium Pyrococcus furiosus (PF-bgl) hydrolyzes the outer sugar at C-6 but not the inner glucose at C-6 or the glucose at C-20. Thus, the combined use of DT-bgl and PF-bgl is expected to increase the biotransformation of PPT-type ginsenosides to APPT. We optimized the ratio of PF-bgl to DTbgl, the concentrations of substrate and enzyme, and the reaction time to increase the biotransformation of ginsenoside Re and PPT-type ginsenosides in Panax ginseng leaf extract to APPT. DT-bgl combined with PF-bgl converted 1.0 mg/ml PPT-type ginsenosides in ginseng leaf extract to 0.58 mg/ml APPT without other ginsenosides, with a molar conversion of 100%. We achieved the complete biotransformation of ginsenoside Re and PPT-type ginsenosides in ginseng leaf extract to APPT by the combined use of two β-glycosidases, suggesting that discarded ginseng leaves can be used as a source of the valuable ginsenoside APPT. To the best of our knowledge, this is the first quantitative production of APPT using ginsenoside Re, and we report the highest concentration and productivity of APPT from ginseng extract to date. J. Microbiol. Biotechnol. [9] , and by β-glucosidases from Acinosynnema mirum [12] , Aspergillus niger [13] , Gordonia terrae [1] , and Penicillum aculeatum [14] , ginsenosidase type IV from Aspergillus sp. 39g [15] , naringinase from Penicillum decumbens [6] , and β-glycosidase from Dictyoglomus turgidum (DT-bgl) [16] . Although ginsenoside Re can be transformed to APPT by human intestinal microflora [9] , the quantitative production of APPT from ginsenoside Re and P. ginseng leaf extract has not been attempted. Moreover, the complete biotransformation of ginseng extract to APPT has not yet been achieved.
Ginsenosides are present in the leaves, stems, flowers, and fruit as well as the roots of ginseng plants [17] [18] [19] . The content of ginsenoside Re in the leaves and fruit is higher than that in the stems, flowers, and roots of ginseng plants, regardless of the extraction solvent used, extraction time, and age of the plant [18, 20] . Ginseng leaf extract is a cheap substrate for APPT production because ginseng leaves are discarded during ginseng harvesting. In this study, we optimized the ratio of DT-bgl to β-glycosidase from Pyrococcus furiosus (PF-bgl) and the concentrations of enzyme and substrate. Under the optimized conditions, the PPT-type ginsenosides in P. ginseng leaf extract were completely converted to the valuable ginsenoside APPT by DT-bgl combined with PF-bgl.
Materials and Methods

Materials
We purchased the ginsenoside standards Re, Rg 
Preparation of Ginseng Leaf Extract
Six-year-old P. ginseng leaf extract was prepared at the National Institute of Horticultural and Herbal Science (Korea). The P. ginseng leaves were dried for 48 h at 40°C in a forced air convection oven. The dried leaves were ground to less than 0.5 mm diameter using a mixer, and thoroughly blended and homogenized using a mixer mill (Retsch MM400; Haan, Germany). The fine leaf powder (100 g) was suspended in 1 L of 80% (v/v) methanol. The mixture was ultrasonically extracted for 1 h at 50°C. The leaf extract was filtered through a 0.45-μm pore filter, methanol in the filtrate was removed using an evaporator, the residue was dissolved in 500 ml of water, and 20% (w/v) of the solvent-free solution was used as the ginseng leaf extract.
Preparation of Enzymes
DT-bgl and PF-bgl were expressed as described previously [20, 21] . Recombinant Escherichia coli ER2566 was cultivated in LB medium mixed with 20 μg/ml kanamycin in a 2-L flask at 37°C. As the OD 6 0 0 (the optical density measured at 600 nm) of the bacterial broth reached 0.6, 0.1 mM isopropyl-β-D-thiogalactopyranoside was supplemented to induce enzyme expression. The bacterial cells were cultivated for a further 16 h at 16°C and harvested. The suspended cells in 50 mM citrate/phosphate buffer (pH 6.0) were disrupted by sonication on ice. The intact cells and cell debris were eliminated by centrifugation at 12,000 ×g for 30 min, and the supernatant was heated at 75°C for 30 min. The insoluble proteins of the heat-treated suspension were eliminated by centrifugation at 12,000 ×g for 30 min. The obtained supernatant was used as an enzyme for the biotransformation of ginsenosides.
Hydrolytic Activity
One unit (U) of DT-bgl or PF-bgl activity was defined as the amount of enzyme required to liberate 1 μmol p-nitrophenol (pNP) from pNP-β-D-glucopyranoside per minute at 80°C and pH 6.0. The substrate specificity was determined after incubation at 80°C for 10 min in 50 mM citrate/phosphate buffer (pH 6.0) containing 0.4 mg/ml Re, Rg ; and 312.5 U/ml for Rf. The specific activity was calculated from the substrate consumption rate.
Optimization of Reaction Conditions Using Ginsenoside Re
The effect of the ratio of PF-bgl to DT-bgl on the biotransformation of ginsenoside Re to APPT was investigated with 0.4 mg/ml Re as a substrate by varying the concentration of DT-bgl from 0.0 to 6.0 mg/ml (0.0 to 50 U/ml) and that of PF-bgl from 1.0 to 0.0 mg/ml (1,040 to 0.0 U/ml). The optimal concentration of ginsenoside Re required for APPT production was determined by varying the concentration of Re from 0.5 to 2.0 mg/ml with 1.2 mg/ml (5.5 U/ml) DT-bgl and 0.8 mg/ml (832 U/ml) PF-bgl. To determine the optimal concentrations of the two enzymes for APPT production, the concentrations of DT-bgl and PF-bgl at the constant weight ratio of 1.2:0.8 were varied from 0.6 and 0.4 mg/ml (5.0 and 416 U/ml) to 4.8 and 3.2 mg/ml (40 and 3,328 U/ml), respectively, with 1.0 mg/ml Re. The optimization reactions were performed in 50 mM citrate/phosphate buffer (pH 6.0) at 80°C for 30 min. The time-course reactions for the biotransformation of ginsenoside Re to APPT were carried out with 1.0 mg/ml Re, 2.4 mg/ml (20 U/ml) DT-bgl, and 1.6 mg/ml (1,664 U/ml) PF-bgl in 50 mM citrate/ phosphate buffer (pH 6.0) at 80°C for 4 h.
Optimization of Reaction Conditions Using Ginseng Leaf Extract
The optimal ratio of DT-bgl to PF-bgl for the conversion of ginseng leaf extract to APPT was determined with ginseng leaf extract containing 1.0 mg/ml PPT-type ginsenosides by varying the concentration of DT-bgl from 0.0 to 7.2 mg/ml (0.0 to 60 U/ml) and the concentration of PF-bgl from 2.25 to 0.0 mg/ml (2,340 to 0.0 U/ml). The effect of substrate concentration on APPT production from ginseng leaf extract was investigated with 5.6 mg/ml (47 U/ml) DT-bgl and 0.5 mg/ml (520 U/ml) PF-bgl by varying the concentration of PPT-type ginsenosides in the leaf extract from 0.5 to 2.0 mg/ml. To determine the optimal enzyme concentration, the concentrations of DT-bgl and PF-bgl at the constant weight ratio of 5.6:0.5 were varied from 2.8 and 0.25 mg/ml (23 and 260 U/ml) to 14.0 and 1.25 mg/ml (117 and 1,300 U/ml), respectively, with the leaf extract containing 1.0 mg/ml PPT-type ginsenosides. The optimization reactions were performed in citrate/phosphate buffer (pH 6.0) at 80°C for 3 h. The time-course reactions for the biotransformation of ginseng leaf extract to APPT were performed with the leaf extract containing 1.0 mg/ml PPTtype ginsenosides, 14.0 mg/ml (117 U/ml) DT-bgl, and 1.25 mg/ml (1,300 U/ml) PF-bgl in 50 mM citrate/phosphate buffer (pH 6.0) at 80°C for 11 h.
Analytical Methods
The ginsenosides were analyzed using a high-performance liquid chromatography (HPLC) system (Agilent 1100; Agilent, USA) with a UV detector set to detect at 203 nm and an octadecylsilica column (250 × 4.6 mm, S-5 μm, and 12 nm; YMC; Dinslaken, Germany). The ginsenosides mixed with the internal standard digoxin were eluted in the column at 30°C by pumping with a linear gradient of water and acetonitrile (70:30 to 30:70 of volume ratio) for 45 min at a flow rate of 1 ml/min.
Results and Discussion
Substrate Specificity of DT-bgl and PF-bgl
The substrate specificity of DT-bgl and PF-bgl toward PPT-type ginsenosides is shown in Table 1 . The specific activity of DT-bgl followed the order of F because it hydrolyzes the glucose and xylose residues in PPT-type ginsenosides but not the rhamnose residue at C-6 in ginsenosides Re and Rg 2 [16] , which can be converted to APPT with the aid of PFbgl. PF-bgl hydrolyzes the outer sugar at C-6 in PPT-type ginsenosides but not the inner glucose at C-6 or the glucose at C-20. Thus, PF-bgl converts Re, Rg (Fig. 1) .
Optimization of Reaction Conditions for the Biotransformation of Ginsenoside Re to APPT by DT-bgl Combined with PF-bgl
The maximal concentrations of DT-bgl and PF-bgl used for the ratio experiments for the biotransformation of ginsenoside Re to APPT were 6.0 and 1.0 mg/ml, respectively, because the specific hydrolytic activity of PF-bgl for ginsenoside Re was 6-fold higher than that of DT-bgl. The biotransformation of Re to APPT was conducted with 0.4 mg/ml Re by varying the concentration of DT-bgl from 0.0 to 6.0 mg/ml and the concentration of PF-bgl from 1.0 to 0.0 mg/ml. After 30 min, the maximum biotransformation of Re to APPT was observed at 1.2 mg/ml DT-bgl and 0.8 mg/ml PF-bgl at a concentration ratio of 3:2 (Fig. 2) . The optimum concentrations of Re, DT-bgl, and PF-bgl were 1.0, 2.4, and 1.6 mg/ml, respectively (Fig. S1 ).
Biotransformation of Ginsenoside Re to APPT by DT-bgl Combined with PF-bgl
The optimal reaction conditions for the biotransformation of ginsenoside Re to APPT were 2.4 mg/ml DT-bgl, 1.6 mg/ml PF-bgl, and 1.0 mg/ml Re at pH 6.0 and 80°C. Under these optimized conditions, the time-course reactions for the biotransformation of Re to APPT were performed using ginsenoside Re for 4 h. DT-bgl combined with PF-bgl converted 1.0 mg/ml Re to 0.5 mg/ml APPT with a productivity of 126 mg/l/h and a molar conversion of 
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100% after 4 h (Fig. 3) . The HPLC profiles during the biotransformation of ginsenoside Re to APPT by DT-bgl supplemented with PF-bgl at 0, 2, and 4 h are presented in Fig. S3 . 
Optimization of Reaction Conditions for the Biotransformation of PPT-Type Ginsenosides in Ginseng Leaf Extract to APPT by DT-bgl Combined with PF-bgl
The P. ginseng leaf extract (20% (w/v)) obtained by extraction with 80% (v/v) methanol contained 2.02 mg/ml PPT-type ginsenosides, which constituted 62.0% (w/w) of the total ginsenosides in ginseng leaf extract ( Table 2 ). The content of specific PPT-type ginsenosides in the total PPTtype ginsenosides in the leaf extract followed the order Re (55.4% (w/w)) > Rg 1 (20.8%) > F 1 (13.9%) > Rf (9.9%), indicating that the efficient hydrolysis of ginsenoside Re is essential for the increased biotransformation of PPT-type ginsenosides in ginseng leaf extract to APPT.
The maximum concentrations of DT-bgl and PF-bgl used for the ratio experiments for the biotransformation of PPTtype ginsenosides in ginseng leaf extract to APPT from ginsenoside Re were 7.2 and 2.25 mg/ml, respectively, because the specific hydrolytic activity of PF-bgl for PPTtype ginsenosides in the leaf extract was approximately 3.2-fold higher than that of DT-bgl. The biotransformation of PPT-type ginsenosides in ginseng leaf extract to APPT was performed with the leaf extract containing 1.0 mg/ml PPTtype ginsenosides by adding PF-bgl to DT-bgl at ratios ranging from 2.25:0 to 0:7.2 mg/ml. After 3 h, the maximum biotransformation of PPT-type ginsenosides in ginseng leaf extract to APPT was observed at 5.6 mg/ml DT-bgl and 0.5 mg/ml PF-bgl (Fig. 4) . The optimum concentrations of PPT-type ginsenosides in the leaf extract, DT-bgl, and PFbgl were 1.0, 14, and 1.25 mg/ml (Fig. S3) . 
Biotransformation of PPT-Type Ginsenosides in Ginseng Leaf Extract to APPT by DT-bgl Combined with PF-bgl
The optimal reaction conditions for APPT production from ginseng leaf extract were 14 mg/ml DT-bgl, 1.25 mg/ml PF-bgl, and the leaf extract containing 1.0 mg/ml PPT-type ginsenosides at pH 6.0 and 80°C. Time-course reactions for the biotransformation of PPT-type ginsenosides in ginseng leaf extract to APPT were performed using the leaf extract containing 1.0 mg/ml PPT-type ginsenosides for 11 h. DTbgl supplemented with PF-bgl converted 1.0 mg/ml PPTtype ginsenosides in ginseng leaf extract to 0.58 mg/ml APPT without other ginsenosides, with a productivity of 53 mg/l/h and a molar conversion of 100% after 11 h (Fig. 5) . The HPLC profiles during the conversion of PPT-type ginsenosides in ginseng leaf extract to APPT by DT-bgl supplemented with PF-bgl at 0, 6, and 11 h are presented in Fig. S4 .
The quantitative production of APPT from PPT-type ginsenosides and ginseng extracts by enzymes is presented in Table 3 . β-Glucosidase from G. terrae converted 4.0 mg/ml Rg 1 to 1.1 mg/ml APPT [20] ; β-glucosidase from A. niger converted Rf to APPT with a molar conversion of 90.4% [13] ; β-glucosidase from Pen. aculeatum converted 0.4 mg/ml Rf to 0.2 mg/ml APPT [14] ; and DT-bgl converted 1 mg/ml R 1 , Rg
1
, and Rf to 0.3, 0.6, and 0.6 mg/ml APPT, respectively [16] . β-Glucosidase from G. terrae had the highest previously reported productivity of APPT owing to high substrate concentration [20] . However, β-glucosidase from G. terrae exhibited low molar conversion and could not be used to produce APPT from ginseng extract because the enzyme did not hydrolyze Rg and Rf to APPT [14, 16, 20] . DT-bgl did not convert Rg 2 and Re to APPT, and did not therefore achieve the complete conversion of ginseng leaf extract to APPT. In contrast, DT-bgl supplemented with PF-bgl completely converted ginsenoside Re and PPT-type ginsenosides in the leaf extract to APPT. In the current study, we enzymatically produced APPT using ginsenoside Re for the first time, and the results represent the highest concentration and productivity of APPT from ginseng extract to date.
In conclusion, DT-bgl completely converted Rg to APPT. Thus, DT-bgl supplemented with PF-bgl completely converts PPT-type ginsenosides in ginseng leaf extract to APPT. To the best of our knowledge, this is the first complete conversion of ginseng extract to APPT, and the reaction system achieved the highest productivity of APPT from ginseng extract to data. Our results demonstrate that DT-bgl supplemented with PF-bgl is an efficient enzyme system for the production of APPT using ginseng leaf extract, and discarded ginseng leaves can be used as a source of the valuable ginsenoside APPT.
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